| Year |
Citation |
Score |
| 2023 |
Trivedi T, Manaa M, John S, Reiken S, Murthy S, Pagnotti GM, Dole NS, She Y, Suresh S, Hain BA, Regan J, Ofer R, Wright L, Robling A, Cao X, ... ... Waning DL, et al. Zoledronic acid improves bone quality and muscle function in a high bone turnover state. Biorxiv : the Preprint Server For Biology. PMID 37333318 DOI: 10.1101/2023.06.01.543305 |
0.363 |
|
| 2022 |
Hain BA, Waning DL. Bone-Muscle Crosstalk: Musculoskeletal Complications of Chemotherapy. Current Osteoporosis Reports. PMID 36087213 DOI: 10.1007/s11914-022-00749-4 |
0.359 |
|
| 2022 |
Wilcox-Hagerty JR, Xu H, Hain B, Waning D. TGFβ Induces Changes in Mitochondrial Homeostasis in Skeletal Muscle of Mice with Bone Metastases. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 35559575 DOI: 10.1096/fasebj.2022.36.S1.L7620 |
0.374 |
|
| 2021 |
Hain BA, Xu H, VanCleave AM, Gordon BS, Kimball SR, Waning DL. REDD1 deletion attenuates cancer cachexia in mice. Journal of Applied Physiology (Bethesda, Md. : 1985). 131: 1718-1730. PMID 34672766 DOI: 10.1152/japplphysiol.00536.2021 |
0.319 |
|
| 2020 |
Chakraborty N, Waning DL, Gautam A, Hoke A, Sowe B, Youssef D, Butler S, Savaglio M, Childress PJ, Kumar R, Moyler C, Dimitrov G, Kacena MA, Hammamieh R. Gene-metabolite network linked to inhibited bioenergetics in association with spaceflight-induced loss of male mouse quadriceps muscle. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 32511780 DOI: 10.1002/Jbmr.4102 |
0.33 |
|
| 2019 |
Hain BA, Jude B, Xu H, Smuin DM, Fox EJ, Elfar JC, Waning DL. Zoledronic acid improves muscle function in healthy mice treated with chemotherapy. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31614017 DOI: 10.1002/Jbmr.3890 |
0.446 |
|
| 2019 |
Hain BA, Xu H, Wilcox JR, Mutua D, Waning DL. Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia. Jcsm Rapid Communications. 2. PMID 31032492 |
0.373 |
|
| 2019 |
Huot JR, Essex AL, Gutierrez M, Barreto R, Wang M, Waning DL, Plotkin LI, Bonetto A. Chronic Treatment with Multi-Kinase Inhibitors Causes Differential Toxicities on Skeletal and Cardiac Muscles. Cancers. 11. PMID 31018508 DOI: 10.3390/Cancers11040571 |
0.37 |
|
| 2019 |
Sturgeon KM, Mathis KM, Rogers CJ, Schmitz KH, Waning DL. Cancer- and Chemotherapy-Induced Musculoskeletal Degradation. Jbmr Plus. 3: e10187. PMID 30918923 DOI: 10.1002/jbm4.10187 |
0.353 |
|
| 2019 |
Waning DL, Guise TA, Mohammad KS. A "Connexin" Responsible for the Fatal Attraction of Cancer to Bone. Cell Metabolism. 29: 6-8. PMID 30625309 DOI: 10.1016/J.Cmet.2018.12.014 |
0.398 |
|
| 2017 |
Regan JN, Mikesell C, Reiken S, Xu H, Marks AR, Mohammad KS, Guise TA, Waning DL. Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model. Frontiers in Endocrinology. 8: 358. PMID 29312148 DOI: 10.3389/Fendo.2017.00358 |
0.409 |
|
| 2017 |
Ross MH, Esser AK, Fox GC, Schmieder AH, Yang X, Hu G, Pan D, Su X, Xu Y, Novack DV, Walsh T, Colditz GA, Lukaszewicz GH, Cordell E, Novack JS, ... ... Waning DL, et al. Bone-induced expression of integrin β3 enables targeted nanotherapy of breast cancer metastases. Cancer Research. PMID 28855208 DOI: 10.1158/0008-5472.Can-17-1225 |
0.399 |
|
| 2017 |
Regan JN, Trivedi T, Guise TA, Waning DL. The Role of TGFβ in Bone-Muscle Crosstalk. Current Osteoporosis Reports. PMID 28161871 DOI: 10.1007/S11914-017-0344-5 |
0.436 |
|
| 2016 |
Wright LE, Harhash AA, Kozlow WM, Waning DL, Regan JN, She Y, John SK, Murthy S, Niewolna M, Marks AR, Mohammad KS, Guise TA. Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo. Oncotarget. PMID 28039445 DOI: 10.18632/Oncotarget.14139 |
0.476 |
|
| 2016 |
Barreto R, Waning DL, Gao H, Liu Y, Zimmers TA, Bonetto A. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs. Oncotarget. PMID 27259276 DOI: 10.18632/Oncotarget.9779 |
0.379 |
|
| 2016 |
Wang H, Cai S, Bailey BJ, Reza Saadatzadeh M, Ding J, Tonsing-Carter E, Georgiadis TM, Zachary Gunter T, Long EC, Minto RE, Gordon KR, Sen SE, Cai W, Eitel JA, Waning DL, et al. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist. Journal of Neurosurgery. 1-14. PMID 27177180 DOI: 10.3171/2016.1.Jns152513 |
0.333 |
|
| 2016 |
Wright L, Harhash A, Waning D, Mohammad K, Marks A, Guise T. Bisphosphonates prevent osteolysis and muscle weakness in aromatase inhibitor-treated mice with breast cancer bone metastases Bone Abstracts. DOI: 10.1530/Boneabs.5.Cabs.Oc4.2 |
0.426 |
|
| 2016 |
Regan J, Waning D, Mohammad K, Mikesell C, Reiken S, Marks A, Guise T. Muscle dysfunction in immune competent mice with osteolytic breast cancer in bone is associated with skeletal muscle oxidation of RyR1 Bone Abstracts. DOI: 10.1530/Boneabs.5.Cabs.Oc4.1 |
0.419 |
|
| 2015 |
Regan JN, Waning DL, Guise TA. Skeletal muscle Ca(2+) mishandling: another effect of bone-to-muscle signaling. Seminars in Cell & Developmental Biology. PMID 26593325 DOI: 10.1016/J.Semcdb.2015.11.007 |
0.432 |
|
| 2015 |
Waning DL, Mohammad KS, Reiken S, Xie W, Andersson DC, John S, Chiechi A, Wright LE, Umanskaya A, Niewolna M, Trivedi T, Charkhzarrin S, Khatiwada P, Wronska A, Haynes A, et al. Excess TGF-β mediates muscle weakness associated with bone metastases in mice. Nature Medicine. PMID 26457758 DOI: 10.1038/Nm.3961 |
0.447 |
|
| 2015 |
Bonetto A, Andersson DC, Waning DL. Assessment of muscle mass and strength in mice. Bonekey Reports. 4: 732. PMID 26331011 DOI: 10.1038/Bonekey.2015.101 |
0.33 |
|
| 2015 |
Stayrook KR, Mack JK, Cerabona D, Edwards DF, Bui HH, Niewolna M, Fournier PG, Mohammad KS, Waning DL, Guise TA. TGFβ-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis. Bonekey Reports. 4: 719. PMID 26157579 DOI: 10.1038/Bonekey.2015.88 |
0.401 |
|
| 2015 |
Waning DL, Guise TA. Cancer-associated muscle weakness: What's bone got to do with it? Bonekey Reports. 4: 691. PMID 25992285 DOI: 10.1038/Bonekey.2015.59 |
0.452 |
|
| 2015 |
Cheng YH, Streicher DA, Waning DL, Chitteti BR, Gerard-O'Riley R, Horowitz MC, Bidwell JP, Pavalko FM, Srour EF, Mayo LD, Kacena MA. Signaling pathways involved in megakaryocyte-mediated proliferation of osteoblast lineage cells. Journal of Cellular Physiology. 230: 578-86. PMID 25160801 DOI: 10.1002/Jcp.24774 |
0.373 |
|
| 2014 |
Waning DL, Guise TA. Molecular mechanisms of bone metastasis and associated muscle weakness. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3071-7. PMID 24677373 DOI: 10.1158/1078-0432.Ccr-13-1590 |
0.443 |
|
| 2013 |
Chiechi A, Waning DL, Stayrook KR, Buijs JT, Guise TA, Mohammad KS. Role of TGF-β in breast cancer bone metastases. Advances in Bioscience and Biotechnology (Print). 4: 15-30. PMID 24558636 DOI: 10.4236/Abb.2013.410A4003 |
0.374 |
|
| 2013 |
Waning DL, Mohammad KS, Guise TA. Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror. Cancer Cell. 24: 407-9. PMID 24135278 DOI: 10.1016/J.Ccr.2013.10.001 |
0.37 |
|
| 2013 |
Cheng YH, Hooker RA, Nguyen K, Gerard-O'Riley R, Waning DL, Chitteti BR, Meijome TE, Chua HL, Plett AP, Orschell CM, Srour EF, Mayo LD, Pavalko FM, Bruzzaniti A, Kacena MA. Pyk2 regulates megakaryocyte-induced increases in osteoblast number and bone formation. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 1434-45. PMID 23362087 DOI: 10.1002/Jbmr.1876 |
0.426 |
|
| 2011 |
Lehman JA, Waning DL, Batuello CN, Cipriano R, Kadakia MP, Mayo LD. Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress. The Journal of Biological Chemistry. 286: 36631-40. PMID 21873427 DOI: 10.1074/Jbc.M110.217620 |
0.31 |
|
| 2010 |
Waning DL, Lehman JA, Batuello CN, Mayo LD. Controlling the Mdm2-Mdmx-p53 Circuit. Pharmaceuticals (Basel, Switzerland). 3: 1576-1593. PMID 20651945 DOI: 10.3390/Ph3051576 |
0.309 |
|
| 2010 |
Waning DL, Mayo LD. Abstract 5069: c-Abl contributes to Mdm2-Mdmx complex formation protecting p53 levels Cancer Research. 70: 5069-5069. DOI: 10.1158/1538-7445.Am10-5069 |
0.308 |
|
| 2008 |
Waning DL, Li B, Jia N, Naaldijk Y, Goebel WS, HogenEsch H, Chun KT. Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis. Blood. 112: 320-9. PMID 18339895 DOI: 10.1182/Blood-2007-11-126300 |
0.372 |
|
| 2007 |
Li B, Jia N, Waning DL, Yang FC, Haneline LS, Chun KT. Cul4A is required for hematopoietic stem-cell engraftment and self-renewal. Blood. 110: 2704-7. PMID 17616641 DOI: 10.1182/Blood-2006-12-064154 |
0.336 |
|
| 2007 |
Chun KT, Waning DL, Li B, Jia N, Naaldijk YM, Goebl WS, HogenEsch H. Cul4A Is Required for Cell Viability and Its Deficiency in Hematopoietic Cells Causes Apoptosis and Is Fatal. Blood. 110: 639-639. DOI: 10.1182/Blood.V110.11.639.639 |
0.391 |
|
| 2004 |
Waning DL, Russell CJ, Jardetzky TS, Lamb RA. Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proceedings of the National Academy of Sciences of the United States of America. 101: 9217-22. PMID 15197264 DOI: 10.1073/Pnas.0403339101 |
0.477 |
|
| 2002 |
Waning DL, Schmitt AP, Leser GP, Lamb RA. Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5. Journal of Virology. 76: 9284-97. PMID 12186912 DOI: 10.1128/Jvi.76.18.9284-9297.2002 |
0.483 |
|
| 2002 |
Schmitt AP, Leser GP, Waning DL, Lamb RA. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. Journal of Virology. 76: 3952-64. PMID 11907235 DOI: 10.1128/Jvi.76.8.3952-3964.2002 |
0.483 |
|
| Show low-probability matches. |